You are here » Home » Companies » Company Overview » Aarti Drugs Ltd

Aarti Drugs Ltd.

BSE: 524348 Sector: Health care
NSE: AARTIDRUGS ISIN Code: INE767A01016
BSE LIVE 13:52 | 05 Dec 645.00 -0.40
(-0.06%)
OPEN

640.00

HIGH

649.00

LOW

640.00

NSE LIVE 13:47 | 05 Dec 647.00 -0.20
(-0.03%)
OPEN

637.00

HIGH

647.95

LOW

637.00

OPEN 640.00
PREVIOUS CLOSE 645.40
VOLUME 678
52-Week high 684.00
52-Week low 431.10
P/E 20.12
Mkt Cap.(Rs cr) 1562.19
Buy Price 645.00
Buy Qty 38.00
Sell Price 646.95
Sell Qty 2.00
OPEN 640.00
CLOSE 645.40
VOLUME 678
52-Week high 684.00
52-Week low 431.10
P/E 20.12
Mkt Cap.(Rs cr) 1562.19
Buy Price 645.00
Buy Qty 38.00
Sell Price 646.95
Sell Qty 2.00

About Aarti Drugs Ltd.

Aarti Drugs Ltd

Aarti Drugs Ltd is one of the leading pharmaceutical manufacturers in India. The company is engaged manufacturing of pharmaceuticals. ADL operates in the anti-diarrhea, anti-inflammatory and anti-biotic therapeutic segments. They manufacture vitamins, anti-arthritis, anti-fungal, antibiotics, antibiotics and angiotensin converting enzyme (ACE) inhibitors in their manufacturing units located at Tar...> More

Aarti Drugs Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   1,562
EPS - TTM () [*C] 32.06
P/E Ratio (X) [*C] 20.12
Face Value ()   10
Latest Dividend (%)   30.00
Latest Dividend Date 22 Mar 2016
Dividend Yield (%) 1.05
Book Value / Share () [*C] 164.88
P/B Ratio () [*C] 3.91
[*C] Consolidated     [*S] Standalone

Aarti Drugs Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 315.69 272.84 15.71
Other Income -
Total Income 315.69 272.84 15.71
Total Expenses 264.55 230.28 14.88
Operating Profit 51.14 42.56 20.16
Net Profit 22.07 15.71 40.48
Equity Capital 24.22 24.22 -
> More on Aarti Drugs Ltd Financials Results

Aarti Drugs Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Bliss GVS Pharma 167.90 0.24 1731.05
Merck 963.60 -0.01 1599.58
Claris Lifescien 293.00 0.84 1598.90
Aarti Drugs 645.00 -0.06 1562.19
Morepen Labs. 22.65 -1.95 1018.91
Alembic 36.10 0.98 964.05
Neuland Labs. 1027.95 0.40 912.82
> More on Aarti Drugs Ltd Peer Group

Aarti Drugs Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 62.65
Banks/FIs 0.06
FIIs 0.60
Insurance 0.00
Mutual Funds 3.96
Indian Public 29.49
Custodians 0.00
Other 3.24
> More on Aarti Drugs Ltd Share Holding Pattern

Aarti Drugs Ltd - Research Reports

Date Broker Action Price Report
09/05 Motilal Oswal Buy 460 PDF IconDetails
09/05 Motilal Oswal Buy 460 PDF IconDetails
> More on Aarti Drugs Ltd Research Reports

Aarti Drugs Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 2.25% 2.28% -0.16% -0.16%
1 Month 4.94% 5.12% -3.54% -3.80%
3 Month 33.66% 34.26% -7.79% -7.90%
6 Month 40.17% 40.65% -1.99% -1.30%
1 Year 16.15% 16.43% 2.62% 4.26%
3 Year 556.49% 557.85% 25.53% 30.00%

Aarti Drugs Ltd - STOCK STRENGTH

Today's Low/High 640.00
649.00
Week Low/High 607.65
650.00
Month Low/High 529.10
650.00
YEAR Low/High 431.10
684.00
All TIME Low/High 2.30
874.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard